Clinical PET of Neuroendocrine Tumors Using⁶⁴Cu-DOTATATE: First-in-Humans Study

Abstract

This first-in-humans study supports the clinical use of (64)Cu-DOTATATE for SRI with excellent imaging quality, reduced radiation burden, and increased lesion detection rate when compared with (111)In-diethylenetriaminepentaacetic acid-octreotide.